Mechanistically, DGCR5 inhibits GBC cell proliferation, migration, invasion and tumor growth via sponging miR-3619-5p and activating MEK/ERK1/2 and JNK/p38 MAPK pathways. Here, MAPK3 is linked to neoplasm.